Abstract
Melanoma of the anorectum represents <2 % of all anorectal cancers and 0.3 % of all primary melanomas. Prognosis is poor, and optimal surgical management is controversial. This series details the surgical management of patients with anorectal melanoma presenting between 2002 and 2013 to the Queen Elizabeth Hospital in Birmingham, UK, a tertiary referral centre for colorectal disease. A retrospective review of patient notes, histology reports, and clinical letters was used to assess perioperative course and long-term outcome of all surgical methods. Eight patients with a median age of 65.5 presented with primary anorectal melanoma during the study period. Six cases were staged as T4 pre-operatively, with two referred as incompletely excised polyps. All eight patients underwent abdominoperineal excision of the rectum (APER), with the most recent four cases undergoing extralevator APER. Clear resection margins were achieved in three out of the four patients in the extralevator APER group with no nodal spread detected at histological assessment. Extralevator APER appears to be feasible and safe in the treatment of melanoma of the anorectum, with 75 % medium-term survival (median 38 months) in selected patients. As it is known that clear margins at surgery are associated with disease-free survival, the wider excision margin at the level of the pelvic floor offered by extralevator APER could result in more favourable surgical outcomes in this prognostically poor malignancy.
References
Singer M, Mutch M (2006) Anal Melanoma. Clin Colon Rectal Surg 19:78–87
Chang AE, Karnell LH, Menck HR (1998) The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 83:1664–1678
Nilsson PJ, Ragnarsson-Olding BK (2010) Importance of clear resection margins in anorectal malignant melanoma. Br J Surg 97:98–103
Yeh JJ, Shia J, Hwu WJ et al (2006) The role of abdominoperineal resection as surgical therapy for anorectal melanoma. Ann Surg 244:1012–1017
Pessaux P, Pocard M, Elias D et al (2004) Surgical management of primary anorectal melanoma. Br J Surg 91:1183–1187
Weyandt GH, Eggert AO, Houf M et al (2003) Anorectal melanoma: surgical management guidelines according to tumour thickness. Br J Cancer 89:2019–2022
Balch CM, Gershenwald JE, Soong S-J et al (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27:6199–6206
Slingluff CL, Vollmer RT, Seigler HF (1990) Anorectal melanoma: clinical characteristics and results of surgical management in twenty-four patients. Surgery 107:1–9
Thibault C, Sagar P, Nivatvongs S et al (1997) Anorectal melanoma—an incurable disease? Dis Colon Rectum 40:661–668
Ross M, Pezzi C, Pezzi T et al (1990) Patterns of failure in anorectal melanoma. A guide to surgical therapy. Arch Surg 125:313–316
van Schaik P-M, Ernst M-F, Meijer H-A, Bosscha K (2008) Melanoma of the rectum: a rare entity. World J Gastroenterol 14:1633–1635
Brady MS, Kavolius JP, Quan SH (1995) Anorectal melanoma. A 64-year experience at Memorial Sloan-Kettering Cancer Center. Dis Colon Rectum 38:146–151
Abbas JS, Karakousis CP, Holyoke ED (1980) Anorectal melanoma: clinical features, recurrence and patient survival. Int Surg 65:423–426
West NP, Anderin C, Smith KJE et al (2010) Multicentre experience with extralevator abdominoperineal excision for low rectal cancer. Br J Surg 97:588–599
Salerno G, Chandler I, Wotherspoon A et al (2008) Sites of surgical wasting in the abdominoperineal specimen. Br J Surg 95:1147–1154
Ni S, Huang D, Chen X et al (2012) c-Kit gene mutation and CD117 expression in human anorectal melanomas. Hum Pathol 43:801–807
Guo J, Si L, Kong Y et al (2011) Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification. J Clin Oncol 29:2904–2909
Conflict of interest
The authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ferguson, H.J.M., Nandi, S., Hejmadi, R.K. et al. A pilot study of extralevator abdominoperineal excision for primary melanoma of the anorectum. Tech Coloproctol 18, 1113–1116 (2014). https://doi.org/10.1007/s10151-014-1209-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10151-014-1209-x